RETARETA
0%
RETATRUTIDE
Investigational peptide · Research use only

INVESTIGATIONAL RETATRUTIDE LY3437943

Retatrutide (LY3437943) is an investigational triple agonist at the GIP, GLP-1 and glucagon receptors. It is not approved as a medicine by any regulator in the world, and it is still in clinical trials. Supplied for laboratory research use only — read the whole page before you decide.

€89.99
Retatrutide — Research Peptide
GIPGLP-1GlucagonNot approved
SCROLL
0
Receptor targets
GLP-1
+ GIP + glucagon
Trials
Still ongoing
Not
Approved
COA
Per batch
About Retatrutide

WHAT IS
ACTUALLY KNOWN

This is a drug in development, not a supplement. Here is the honest state of the evidence.

01

The mechanism

A single peptide designed to act at three receptors: GIP, GLP-1 and glucagon. That much is well documented.

02

Where the trials are

Phase 2 obesity results were published in the New England Journal of Medicine in 2023. Phase 3 is still running. Nothing is finished.

03

Approved by nobody

No regulator anywhere — MHRA, EMA, FDA — has authorised retatrutide for any use. It is not a licensed medicine.

04

Trials used injection

The published trials administered retatrutide subcutaneously. This product is a capsule. Peptides taken by mouth are largely broken down in the gut.

05

Known adverse effects

Trial participants reported nausea, vomiting, diarrhoea and constipation, and dose escalation was managed by clinicians throughout.

06

What we do verify

Identity and purity, per batch, by a laboratory we do not own. We verify what is in the capsule — nothing about what it does.

The breakdown

SPEC SHEET

What is in the bottle, and what is on the certificate.

agonist

GIP · GLP-1 · Glucagon

Retatrutide (LY3437943) is designed to act at all three receptors.

Oralcapsule

Format

Supplied as a capsule. The clinical trials used subcutaneous injection; oral bioavailability of peptides is generally very low.

Labresearch use

Research use only

We do not publish a human dosing protocol for this compound.

COAper batch

Independently assayed

Each batch is assayed by Janoshik Analytical, an independent laboratory. The Certificate of Analysis for your batch is available on request.

This product is supplied for laboratory research use only. We do not provide dosing instructions or titration schedules for human use. If you are seeking treatment for obesity or diabetes, speak to a doctor — there are licensed medicines for that, and this is not one of them.

Retatrutide — Research Peptide

RETATRUTIDE LY3437943

Investigational peptide · research use only
€89.99

Tax included · research peptide · assayed per batch

Total: €89.99
or browse the full range →
Independently assayed per batch
Free, discreet UK delivery
In stock
Verification

WHAT WE CAN
PROVE

We don't have customer reviews to show you yet, and we're not going to invent any. Here is what we can actually put in front of you instead.

Assayed by a lab we don't own

Batches go to Janoshik Analytical, an independent testing laboratory. We don't choose the result.

Tested per batch, not per year

A certificate from a batch made two years ago says nothing about the pack in your hand.

Batch number on the pack

Email it to us with the product name and we'll send the Certificate of Analysis for that batch.

Good to know

QUESTIONS, ANSWERED

An investigational peptide (LY3437943) designed to act at the GIP, GLP-1 and glucagon receptors. It is a drug in clinical development, not a supplement.

No. Not by the MHRA, not by the EMA, not by the FDA, not by anyone. Phase 3 trials are still running. Anyone telling you otherwise is wrong.

This product is supplied for laboratory research use only. We do not publish dosing or titration guidance for human use.

A fair question, and we would rather you asked it than not. The published trials used subcutaneous injection. Peptides taken by mouth are largely degraded by digestive enzymes before absorption. We are not going to claim an oral capsule reproduces trial results.

No. Speak to a doctor. There are licensed weight-management medicines with approved safety profiles and clinical supervision. This is not one of them and we are not selling it as one.

Yes — identity and purity, per batch, by Janoshik Analytical. Email us the batch number from your pack and we will send that batch's Certificate of Analysis.

RETA

RESEARCH COMPOUND

Assayed per batch, certificate on request. Not approved as a medicine anywhere. €89.99.

I WANT RETATRUTIDE

Sold as a research compound for laboratory and educational use. Retatrutide is an investigational drug that has not been approved by the MHRA, EMA, FDA or any other regulator. Not a medicine; not intended to diagnose, treat, cure or prevent any disease; not a substitute for medically supervised weight-management treatment. Not for human consumption. Not for anyone under 18, or anyone who is pregnant or breastfeeding.

Shipping

UK: free delivery, 2–3 business days.
EU & worldwide: calculated at checkout, fully tracked. Discreet, plain packaging on every order.

Returns

30-day returns on unopened items in original packaging. Return shipping is paid by the customer. Email us to start a return.

Secure & Tested

SSL-encrypted, GDPR-compliant checkout. Every batch is third-party lab-tested (Janoshik) — certificate of analysis available on request.

FreeMuscle LTD

Frodingham, Scunthorpe, North Lincolnshire, DN15 8RN, United Kingdom
freemuscleuk@gmail.com
Mon–Fri 9:00–17:00 GMT

VISAMastercardApple PaySSL Secure